Trevi Therapeutics, Inc. (TRVI)
NASDAQ·Healthcare·Biotechnology
$14.53
+1.36%
Mkt Cap $1.93B
Analyst Ratings
Buy
7
Hold
0
Sell
0
Price Target (14 analysts)
$29.67
Range $23.00 – $40.00
Implied Upside
+104.3%
Consensus $29.67 vs current $14.53
NASDAQ·Healthcare·Biotechnology
$14.53
+1.36%
Mkt Cap $1.93B
Buy
7
Hold
0
Sell
0
Price Target (14 analysts)
$29.67
Range $23.00 – $40.00
+104.3%
Consensus $29.67 vs current $14.53